Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Morris

Showing results (151-160 of 173) with videos related to

Pageof 18
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1988
The disposition of carboplatin in ovarian cancer patientsR C Gaver, N Colombo, M D Green, et al.
The British Journal of Dermatology|September 1, 1999
Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasisC M Clark, B Kirby, A D Morris, et al.
European Journal of Pain (London, England)|July 1, 2014
A genome-wide association study suggests an association of Chr8p21.3 (GFRA2) with diabetic neuropathic painW Meng, H A Deshmukh, N R van Zuydam, et al.
Diabetes Care|May 20, 1998
Diabetes and lower-limb amputations in the community. A retrospective cohort study. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland/Medicines Monitoring UnitA D Morris, R McAlpine, D Steinke, et al.
Diabetologia|May 25, 2011
Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology GroupL Govan, O Wu, A Briggs, et al.
Clinical Pharmacology and Therapeutics|December 24, 2010
Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS studyL A Donnelly, A S F Doney, R Tavendale, et al.
Diabetologia|June 27, 2012
The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetesL Govan, E Maietti, B Torsney, et al.
Clinical Pharmacology and Therapeutics|October 2, 2009
Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS studyK Zhou, L Donnelly, L Burch, et al.
Diabetologia|October 1, 2011
Do men develop type 2 diabetes at lower body mass indices than women?J Logue, J J Walker, H M Colhoun, et al.
British Journal of Cancer|May 12, 2005
Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort studyA J Swerdlow, S P Laing, Z Qiao, et al.
Pageof 18

Showing results (151-160 of 173) with videos related to

Sort By:
Pageof 18
Cancer Chemotherapy and Pharmacology|January 1, 1988
The disposition of carboplatin in ovarian cancer patientsR C Gaver, N Colombo, M D Green, et al.
The British Journal of Dermatology|September 1, 1999
Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasisC M Clark, B Kirby, A D Morris, et al.
European Journal of Pain (London, England)|July 1, 2014
A genome-wide association study suggests an association of Chr8p21.3 (GFRA2) with diabetic neuropathic painW Meng, H A Deshmukh, N R van Zuydam, et al.
Diabetes Care|May 20, 1998
Diabetes and lower-limb amputations in the community. A retrospective cohort study. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland/Medicines Monitoring UnitA D Morris, R McAlpine, D Steinke, et al.
Diabetologia|May 25, 2011
Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology GroupL Govan, O Wu, A Briggs, et al.
Clinical Pharmacology and Therapeutics|December 24, 2010
Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS studyL A Donnelly, A S F Doney, R Tavendale, et al.
Diabetologia|June 27, 2012
The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetesL Govan, E Maietti, B Torsney, et al.
Clinical Pharmacology and Therapeutics|October 2, 2009
Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS studyK Zhou, L Donnelly, L Burch, et al.
Diabetologia|October 1, 2011
Do men develop type 2 diabetes at lower body mass indices than women?J Logue, J J Walker, H M Colhoun, et al.
British Journal of Cancer|May 12, 2005
Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort studyA J Swerdlow, S P Laing, Z Qiao, et al.
Pageof 18